Ascrinvacumab (PF-03446962) is a human IgG2 моноклональный антитело targets ALK-1. Ascrinvacumab shows связывание efficiency with human ALK1 with a Kd value of 7 nM. Ascrinvacumab can be used for the research of hepatocellular carcinoma (HCC).
Ascrinvacumab (PF-03446962) is a human IgG2 monoclonal antibody targets ALK-1. Ascrinvacumab shows binding efficiency with human ALK1 with a Kd value of 7 nM. Ascrinvacumab can be used for the research of hepatocellular carcinoma (HCC).
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.